Skip to main content
WVE
NASDAQ Life Sciences

FDA Backs Registrational Path for Wave's RNA Editing Drug in AATD

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.71
Mkt Cap
$729.078M
52W Low
$3.555
52W High
$21.73
52W Position info
4.4% above low
Off High info
83% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

WVE is trading near its 52-week low of $3.555 (4.4% above the low).

Summary

Wave Life Sciences announced FDA alignment on a registrational pathway for WVE-006, its RNA editing therapy for AATD. The agency supports a single two-year trial with a one-year interim analysis for potential accelerated approval based on biomarkers. This de-risks the program and could shorten time to market. The company also confirmed FDA acceptance of its current LC-MS assay. Data from the ongoing Phase 1b/2a RestorAATion-2 trial's 600 mg cohort is expected in Q4 2026.

At the time of this announcement, WVE was trading at $3.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $729.1M. The 52-week trading range was $3.56 to $21.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

WVE - Latest Insights

WVE
Oct 27, 2026, 7:50 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.42
Real-time Price: $2.69 info
Change: -$0.7299 (-21%) info
Market Cap: $536.463M info
WVE
Oct 27, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.45
Real-time Price: $2.69 info
Change: -$0.7599 (-22%) info
Market Cap: $536.463M info
WVE
Sep 23, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.50
Real-time Price: $2.69 info
Change: -$1.81 (-40%) info
Market Cap: $536.463M info
WVE
Aug 07, 2026, 4:52 PM EDT
Filing Type: 8-K12B
Importance Score:
7
Price at Filing: $6.14
Real-time Price: $2.69 info
Change: -$3.45 (-56%) info
Market Cap: $536.463M info
WVE
Jul 30, 2026, 7:50 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.38
Real-time Price: $2.69 info
Change: -$2.69 (-50%) info
Market Cap: $536.463M info